Navigation Links
Epstein-Barr Virus EBNA-1 IgG II

ProductsEpstein-Barr Virus EBNA-1 IgG II
Company Inverness Medical Innovations
Item Epstein-Barr Virus EBNA-1 IgG II
Features All kits include the following:
  • 12 x 8 well strips with breakaway wells
  • Controls and calibrators
  • TMB substrate
  • Stop solution
  • Directional insert
  • Sample diluent
  • Conjugate
  • Wash buffer
Description Our breadth of infectious disease ELISA products make us a leader in this field. With standard assay protocols for faster integration into the busy laboratory, our Infectious Disease ELISA products provide increased reliability and run-to-run consistency. Our Infectious Disease ELISA menu includes antibody detection assays for a wide range of serological assays including ToRCH, EBV, H. pylori and Lyme, among many others.
Info Inverness Medical Innovations
Customer Service: 800-257-9525
Web site: http://www.invernessmedical.com/

Related medicine products :

1. Epstein-Barr Virus (EBV) Early Antigen IFA
2. Epstein-Barr Nuclear Antigen (EBNA) ACIF (Anti-Complement Immunofluorescence)
3. Epstein-Barr Virus (EBV) VCA IgM Recombinant IFA (RIFA)
4. Epstein-Barr Virus (EBV) VCA IFA IgG
5. Epstein-Barr virus (EBV) ELISA
6. Epstein-Barr Virus EBV-VCA IgG II
7. Epstein-Barr Virus EBV-EA IgG II
8. Epstein-Barr Virus EBV-VCA IgM II
9. Epstein-Barr Virus (EBV) Probe, Paraffin
10. Epstein-Barr Virus Antibody Panel II
11. Epstein-Barr Virus Antibody Panel I
Microscissors : Horizontal Scissors
Microscissors : Vertical Scissors
Sharp tipped scissors with a curvature of 12 mm to follow the contour of the retina. For cutting in the plane parallel to the retina, cutting membranes adherent to the retinal surface and all purpose
The Focus Diagnostics Rickettsia Indirect Immunofluorescence Antibody (IFA) IgM test is intended for the detection and semi-quantitation of human IgM class antibodies to Spotted Fever and Typhus Feve
Medicine Products:
(Date:12/3/2008)...ewswire/ -- The American Society of Hematology (AS...f blood specialists, expects more than 20,000 atte... 6-9, 2008, at the Moscone Center in San Francisco...h and treatments for blood disorders. In honor of ...be several special programs including a unique vid...
(Date:12/3/2008)...e of Technology has extended its military scholars...erved in Iraq or Afghanistan. This scholarship pro...also available to spouses and dependents of milita...o $150,000 in scholarships is available for studen... or Medical Careers Institute, the School of Healt...
(Date:12/3/2008)...new study led by researchers at Albert Einstein Co...ied how two major variants of HIV differ in their ...nding, published in Journal of Neuroscience , hig...HIV-associated dementia, an incurable and increasi... with anti-retroviral drug therapies, up to one-ha...
(Date:12/3/2008)... were free of tumor recurrence an average of 15 ye...Dec. 3 A new Mayo Clini... survived longest when they underwent aggressive s...If safely removing the entire tumor was not possib...rgery was followed by radiation therapy. This stud...
Breaking Medicine News(10 mins):Health News:50th Annual Meeting of the American Society of Hematology Will Feature Breakthrough Research in Blood Diseases 2Health News:50th Annual Meeting of the American Society of Hematology Will Feature Breakthrough Research in Blood Diseases 3Health News:50th Annual Meeting of the American Society of Hematology Will Feature Breakthrough Research in Blood Diseases 4Health News: ECPI College of Technology and Medical Careers Institute Announce Extension for South Carolina Military Scholarship Opportunity 2Health News:Study sheds light on causes of HIV dementia 2Health News:Study sheds light on causes of HIV dementia 3Health News:Mayo Clinic Identifies Best Treatments for Long-Term Survival in Brain Tumor Patients 2Health News:Mayo Clinic Identifies Best Treatments for Long-Term Survival in Brain Tumor Patients 3
...tigating the potential beneficial effects of TNFa ... effects of anti-TNFa treatment in aging," appears...athology. This study shows hope for significantly...nactivating TNFa, which has been linked to blood v...
...l Association (IMA) will oppose the government's p... injections.// "The IMA will oppose the move to ad...se immunisation," IMA's outgoing national presiden...ere. Malik was here to attend the first IMA natio...
...s (SSc) is a chronic autoimmune disorder marked by...rosis.// More than skin deep, this thickening and ...apillaries, the gastrointestinal tract, the lungs,...tly leads to organ dysfunction, serious illness, a...
...succumbed to Rift Valley Fever in Garissa district...s effect has been made by the North Eastern Provin...e Medical officer has cautioned the public to seek...ble, as the most important reason for the spread o...
Other Medicine News:Health News:Effects Of Age-related Vascular Diseases Can Be Reduced By Inactivating TNFa 2Health News:New Treatment Offers Hope for Systemic Sclerosis 2
(Date:12/3/2008)...e Leukemia & Lymphoma Society (LLS) and Memgen...ical trial of ISF35, a cancer vaccine, at the Uni..., LLS is collaborating on this trial in the hop... of a novel approach aimed at treating patients wi...ic lymphocytic leukemia (CLL). , , Doctors...
(Date:12/3/2008)...l/ -- Isis Pharmaceuticals,Inc. (Nasdaq: ISIS ...Inc.,provided positive survival results from a ra...bination with docetaxel and prednisone ("the OGX-0...ne ("the control arm") for first-line,treatment o...The current 10.6,month median overall survival ad...
(Date:12/2/2008)...searchers using functional,MRI (fMRI) have determ...responsible for suppressing memory is dysfunctiona...iatric disorders. Results of the study will be pre...gical Society of North America,(RSNA). , "...s-related disorders,traumatic memories are a sou...
(Date:12/2/2008)...ratories, a leading clinical-diagnostics and biom...ogy and allergy assays, announced that it has laun...nts whose immune systems may be compromised due to... drugs, or because they are taking immuno-suppress...e company launched the two new assays, the T Cell...
Breaking Medicine Technology:The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial 2The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial 3Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 2Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 3Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 4Stress-Related Disorders Affect Brain's Processing of Memory 2Stress-Related Disorders Affect Brain's Processing of Memory 3IBT Laboratories Expands its Menu of Tests for Immune Deficiency 2Isolagen Inc Completes Enrollment in Isolagen Therapy 28TM 29 Phase II III Acne Scar Study 1520 1Isolagen Inc Completes Enrollment in Isolagen Therapy 28TM 29 Phase II III Acne Scar Study 1520 2Isolagen Inc Completes Enrollment in Isolagen Therapy 28TM 29 Phase II III Acne Scar Study 1520 3Legal exposure to asbestos like material linked to lung damage 25 years later 14381 1Legal exposure to asbestos like material linked to lung damage 25 years later 14381 2Legal exposure to asbestos like material linked to lung damage 25 years later 14381 3Murad Inc Hires Lori Jacobus as Vice President of Global Marketing 14380 1Murad Inc Hires Lori Jacobus as Vice President of Global Marketing 14380 2Option to Develop Exelixis Compound Exercised By Genentech 3969 1Option to Develop Exelixis Compound Exercised By Genentech 3969 2Option to Develop Exelixis Compound Exercised By Genentech 3969 3Option to Develop Exelixis Compound Exercised By Genentech 3969 4
...KE, Va.--(BUSINESS WIRE)--Jun 20, 2007 - Researche...A) and Virginia Commonwealth,University (VCU) are ...es referred to as "buckyballs," are able to block ...s and mice. These findings,are described in a pape...lergic Response" published in the July 1 issue of ...
...DIEGO, June 19, 2007 /PRNewswire-FirstCall/ -- Amy...a featuring its,approved diabetes drugs, BYETTA(R)...acetate) injection, and its pipeline,candidates wi...on,s,(ADA) 67th Annual Scientific Sessions being h... will also host an investor,presentation during th...
Other Medicine Technology:First Demonstration of nanoImmunology: a Nanomaterials-based,Therapeutic Approach to Treat Allergy 2First Demonstration of nanoImmunology: a Nanomaterials-based,Therapeutic Approach to Treat Allergy 3Amylin Pharmaceuticals to Present New Data from Broad Diabetes and,Obesity Programs at ADA 2007 2Amylin Pharmaceuticals to Present New Data from Broad Diabetes and,Obesity Programs at ADA 2007 3Amylin Pharmaceuticals to Present New Data from Broad Diabetes and,Obesity Programs at ADA 2007 4